Products found to contain undeclared medicines
|
|
The United States: Public Notification: “XIYOUJI QINGZHI CAPSULE” Contains Hidden Drug Ingredient Sibutramine |
|
FDA is advising consumers not to purchase or use “XIYOUJI QINGZHI CAPSULE”, a product promoted and sold for weight loss on various websites, including www.jadera.net. FDA laboratory analysis confirmed that “XIYOUJI QINGZHI CAPSULE” contains sibutramine. Sibutramine is a controlled substance that was removed from the US market in October 2010 for safety reasons. The product poses a threat to consumers because sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This product may also interact, in life threatening ways, with other medications a consumer may be taking. Consumers should stop using this product immediately and throw it away. Consumers who have experienced any negative side effects should consult a healthcare professional as soon as possible.
Please refer to the following website in FDA for details:
http://www.fda.gov/Drugs/ResourcesForYou/../ucm355797.htm
In Hong Kong, the above product is not a registered pharmaceutical product. Related news has been released by TGA and Health Canada, and was posted on Drug Office website on 9 March and 25 May 2012 respectively.
Ends/ Tuesday, June 11, 2013
Issued at HKT 12:00
|
|
|